Leber Congenital Amaurosis 5-Like (LCA5L) Peptide
LCA5L
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all LCA5L products
- LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- GSEEPLQSKE SHPLPPSQAS TSHAFGDSKV TVVNSIKPSS PTEGKRKIII
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of C21 orf13 antibody,
Alternative Names: C21ORF13 control peptide, C21ORF13 antibody Blocking Peptide, Anti-C21ORF13 Blocking Peptide, MGC33295 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- LCA5L (Leber Congenital Amaurosis 5-Like (LCA5L))
- Synonyms
- C21orf13 Peptide, 4921526F01Rik Peptide, Lcca5l Peptide, Leber congenital amaurosis 5-like Peptide, LCA5L, lebercilin like Peptide, LCA5L Peptide, Lca5l Peptide
- Background
- The function of the C21orf13 protein has not been widely studied, and is yet to be fully elucidated.
- Molecular Weight
- 76 kDa
-
You are here:
